| Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency. Ishida F., Okubo K., Ito T., Okumura N., Souri M., Ichinose A.
Thromb. Haemost. 104:1284-1285(2010) · Mapped (4) |
| A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia. Fujihara N., Haneishi A., Yamauchi K., Terasawa F., Ito T., Ishida F., Okumura N.
Thromb. Haemost. 104:213-223(2010) · Mapped (3) |
| Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population. Obama K., Makishima H., Ishida F.
Leuk. Lymphoma 51:1580-1581(2010) · Mapped (62) |
| Close resemblance between chemokine receptor expression profiles of lymphoproliferative disease of granular lymphocytes and their normal counterparts in association with elevated serum concentrations of IP-10 and MIG. Momose K., Makishima H., Ito T., Nakazawa H., Shimodaira S., Kiyosawa K., Ishida F.
Int. J. Hematol. 86:174-179(2007) · Mapped (3) |
| Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma. Asano N., Suzuki R., Matsuo K., Kagami Y., Ishida F., Tamaru J.I., Jin G.S., Sato Y., Shimoyama Y., Yoshino T. et al.
Histopathology 50:705-715(2007) · Mapped (11) |
| Chemokine system and tissue infiltration in aggressive NK-cell leukemia. Makishima H., Ito T., Momose K., Nakazawa H., Shimodaira S., Kamijo Y., Nakazawa Y., Ichikawa N., Ueno M., Kobayashi H. et al.
Leuk. Res. 31:1237-1245(2007) · Mapped (3) |
| Significance of chemokine receptor expression in aggressive NK cell leukemia. Makishima H., Ito T., Asano N., Nakazawa H., Shimodaira S., Kamijo Y., Nakazawa Y., Suzuki T., Kobayashi H., Kiyosawa K. et al.
Leukemia 19:1169-1174(2005) · Mapped (25) |
| A missense mutation (Tyr88 to Cys) in the platelet membrane glycoprotein Ibbeta gene affects GPIb/IX complex expression--Bernard-Soulier syndrome in the homozygous form and giant platelets in the heterozygous form. Kurokawa Y., Ishida F., Kamijo T., Kunishima S., Kenny D., Kitano K., Koike K.
Thromb. Haemost. 86:1249-1256(2001) · Mapped (1) |
| Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Ib alpha with human platelet antigen-2 and variable number of tandem repeats polymorphism, and its relationship with coronary artery disease. Ishida F., Ito T., Takei M., Shimodaira S., Kitano K., Kiyosawa K.
Br. J. Haematol. 111:1247-1249(2000) · Mapped (7) |
| Molecular study of eight Japanese cases of glucose-6-phosphate dehydrogenase deficiency by nonradioisotopic single-strand conformation polymorphism analysis. Hirono A., Miwa S., Fujii H., Ishida F., Yamada K., Kubota K.
Blood 83:3363-3368(1994) · UniProtKB (1) |
| The largest variant of platelet glycoprotein Ib alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine145. Ishida F., Furihata K., Ishida K., Yan J., Kitano K., Kiyosawa K., Furuta S.
Blood 86:1357-1360(1995) · UniProtKB (1) |
| Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ib alpha involved in platelet transfusion refractoriness. Murata M., Furihata K., Ishida F., Russell S.R., Ware J., Ruggeri Z.M.
Blood 79:3086-3090(1992) · UniProtKB (1) |
